These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19154222)

  • 1. Should adjunctive antipsychotic treatment be continued in remitted patients with depression?
    Uchida H; Suzuki T; Watanabe K; Kashima H
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):126. PubMed ID: 19154222
    [No Abstract]   [Full Text] [Related]  

  • 2. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation.
    Blier P; Gobbi G; Turcotte JE; de Montigny C; Boucher N; Hébert C; Debonnel G
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):457-65. PubMed ID: 19345072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression.
    Mihaljevic Peles A; Bozina N; Sagud M; Rojnic Kuzman M; Lovric M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1439-44. PubMed ID: 18550244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion augmentation in the treatment of chronic fatigue syndrome with coexistent major depression episode.
    Schönfeldt-Lecuona C; Connemann BJ; Wolf RC; Braun M; Freudenmann RW
    Pharmacopsychiatry; 2006 Jul; 39(4):152-4. PubMed ID: 16871471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
    Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
    J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports.
    Luis Blay S
    Ann Clin Psychiatry; 2006; 18(4):271-2. PubMed ID: 17162628
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of neuroleptics on depressive symptoms].
    Tabeze JP
    Encephale; 1998 Jul; 24 Spec No 1():38-41. PubMed ID: 9809254
    [No Abstract]   [Full Text] [Related]  

  • 8. Cognitive predictors of treatment response to bupropion and cognitive effects of bupropion in patients with major depressive disorder.
    Herrera-Guzmán I; Gudayol-Ferré E; Lira-Mandujano J; Herrera-Abarca J; Herrera-Guzmán D; Montoya-Pérez K; Guardia-Olmos J
    Psychiatry Res; 2008 Jul; 160(1):72-82. PubMed ID: 18501971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.
    Chan JH; Chen CH; Robson D; Tan HK
    Psychiatry Clin Neurosci; 2009 Feb; 63(1):125-6. PubMed ID: 19154221
    [No Abstract]   [Full Text] [Related]  

  • 10. Augmentation of paroxetine with clocapramine in panic disorder.
    Saito M; Miyaoka H
    Psychiatry Clin Neurosci; 2007 Aug; 61(4):449. PubMed ID: 17610675
    [No Abstract]   [Full Text] [Related]  

  • 11. Using psychostimulants for treating residual symptoms in major depression.
    Berlim MT; Turecki MG
    J Psychiatry Neurosci; 2007 Jul; 32(4):304. PubMed ID: 17653297
    [No Abstract]   [Full Text] [Related]  

  • 12. Exacerbation of extrapyramidal symptoms with paroxetine.
    Arya DK; McKenzie J; Worrall N
    Aust N Z J Psychiatry; 1995 Sep; 29(3):521-2. PubMed ID: 8573063
    [No Abstract]   [Full Text] [Related]  

  • 13. Perospirone augmentation of paroxetine in treatment of refractory obsessive-compulsive disorder with depression.
    Otsuka T; Togo T; Sugiyama N; Uehara K; Yoshimi A; Karashima A; Shioya H; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):564-6. PubMed ID: 17166643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The modern pharmacopoeia: a return to depressive realism?
    Goldberg JF
    Bipolar Disord; 2008 Dec; 10(8):969-72. PubMed ID: 19594511
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of blonanserin in combination therapy for treatment-resistant depression.
    Kumagai R; Ichimiya Y
    Psychiatry Clin Neurosci; 2009 Aug; 63(4):593-4. PubMed ID: 19659567
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of lamotrigine on platelet serotonin concentration in patients with bipolar depression.
    Sagud M; Pivac N; Mustapic M; Nedic G; Peles AM; Kramaric M; Jakovljevic M; Muck-Seler D
    Psychopharmacology (Berl); 2008 May; 197(4):683-5. PubMed ID: 18246328
    [No Abstract]   [Full Text] [Related]  

  • 17. High CSF Tau-protein concentration in delirium induced by high dose psychiatric medication.
    Windhagen A; Wurster U; Kropp S; Ziegenbein M
    Aust N Z J Psychiatry; 2006; 40(11-12):1039-41. PubMed ID: 17054574
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful treatment by paroxetine of delusional disorder, somatic type, accompanied by severe secondary depression.
    Hayashi H; Akahane T; Suzuki H; Sasaki T; Kawakatsu S; Otani K
    Clin Neuropharmacol; 2010; 33(1):48-9. PubMed ID: 19935408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Augmentation of milnacipran by risperidone in treatment for major depression.
    Tani K; Takei N; Kawai M; Suzuki K; Sekine Y; Toyoda T; Minabe Y; Mori N
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):55-8. PubMed ID: 14731310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical picture and treatment of panic disorder accompanied with generalized anxiety].
    Reznik AM; Arbuzov AL; Khurbatova IG
    Voen Med Zh; 2007 Jan; 328(1):38-43. PubMed ID: 17436713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.